Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Monthly program pricing starts at $425 and includes medical oversight, evaluation, and ongoing support
Always keep them in dark containers or away from direct sunlight and strong artificial light
Most patients experience no discomfort
After the initial introduction of SGLT2i in 2013 [9] and following demonstration of kidney and cardiovascular outcome benefits for patients with type 2 diabetes, in 2021 the US Food and Drug Administration (FDA) provided the first indication that SGLT2i reduced the risk of kidney disease progression in patients with CKD [10, 11]
US$ 22.73
US$ 21.11
US$ 25.29
US$ 21.60
US$ 28.51
.webp)
US$ 24.39
